Evidence map›Paper›PMID 42507597›Full record

ArticleMicrobial genomics2026

Performance of mechanically sheared DNA in multiplexed Oxford Nanopore sequencing for

Hsu Thinzar Maung, Masamoto Morita, Su Myat Han, Hiroyuki Mishima, Chisa Koga, Jan Wendzl C Evangelista, Mark John Girasol, Shuichi Suzuki, Koh-Ichiro Yoshiura, Toshio Kodama and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbial genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Hsu Thinzar MaungSchool of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan.
Masamoto MoritaDepartment of Bacteriology I, National Institute of Infectious Diseases (NIID), Japan Institute for Health Security, Tokyo, Japan.
Su Myat HanSchool of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan.
Hiroyuki MishimaDepartment of Human Genetics, Atomic Bomb Disease Institute (GENKEN), Nagasaki University, Nagasaki, Japan.
Chisa KogaDepartment of Human Genetics, Atomic Bomb Disease Institute (GENKEN), Nagasaki University, Nagasaki, Japan.
Jan Wendzl C EvangelistaSan Lazaro Hospital-Nagasaki University Research and Training Collaborating Center (SLH-NU), Manila, Philippines.
Mark John GirasolSan Lazaro Hospital-Nagasaki University Research and Training Collaborating Center (SLH-NU), Manila, Philippines.
Shuichi SuzukiSchool of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan.
Koh-Ichiro YoshiuraDepartment of Human Genetics, Atomic Bomb Disease Institute (GENKEN), Nagasaki University, Nagasaki, Japan.
Toshio KodamaDepartment of Bacteriology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.
Chris SmithSchool of Tropical Medicine and Global Health (TMGH), Nagasaki University, Nagasaki, Japan.
Hirotaka HiyoshiDepartment of Bacteriology, Institute of Tropical Medicine (NEKKEN), Nagasaki University, Nagasaki, Japan.

Funding

Wellcome Trust
6 · The paper itself

Abstract

Pathogen genomic surveillance is essential for monitoring high-risk lineages and antimicrobial resistance in

Indexed as

DNA, BacterialNanopore SequencingSalmonella typhiGenome, BacterialGenomicsHigh-Throughput Nucleotide SequencingHumansPolymorphism, Single NucleotideSequence Analysis, DNATyphoid FeverWhole Genome SequencingDNA, Bacterialgenomic surveillancemechanical DNA shearingmultiplex sequencingOxford Nanopore TechnologiesSalmonella Typhityphoid

Identifiers

PMID42507597
PMCPMC13405487

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.